150 results on '"Lezon-Geyda, Kimberly"'
Search Results
2. Epigenetic Remodeling in Human Coronary Artery Smooth Muscle Cell Phenotypic Switching
3. Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study
4. Aberrant splicing contributes to severe [alpha]-spectrin-linked congenital hemolytic anemia
5. Novel mechanisms of PIEZO1 dysfunction in hereditary xerocytosis
6. Mutations in the Gardos channel (KCNN4) are associated with hereditary xerocytosis
7. Global transcriptome analysis and enhancer landscape of human primary T follicular helper and T effector lymphocytes
8. Deletion of Mecom in mouse results in early-onset spinal deformity and osteopenia
9. Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity
10. Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapy
11. PR-domain–containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function
12. Brief-exposure to preoperative bevacizumab reveals a TGF-β signature predictive of response in HER2-negative breast cancers
13. Regulation of RNA polymerase II activity is essential for terminal erythroid maturation
14. Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin–bound paclitaxel in patients with advanced solid tumors
15. Multimodality Platelet Evaluation By Mass Cytometry and Genetic Analysis in Patients with Bleeding Disorders
16. Identification of a Novel Gene Regulatory Element in Human Erythroid Progenitor Cells
17. Genotype-Phenotype Correlation and Molecular Heterogeneity in Pyruvate Kinase Deficiency
18. Chromosome 7 Aneusomy in Metaplastic Breast Carcinomas With Chondroid, Squamous, and Spindle-Cell Differentiation
19. Genotype‐phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency
20. A Ser725Arg mutation in Band 3 abolishes transport function and leads to anemia and renal tubular acidosis
21. Terminal Erythroid Maturation Is Associated with Dynamic Changes in the Abundance of Histone Marks Associated with Active Transcription Elongation and RNA Polymerase II Pausing
22. A Unique Epigenomic Landscape Defines Human Erythropoiesis
23. Aberrant splicing contributes to severe α-spectrin–linked congenital hemolytic anemia
24. Clinical spectrum of pyruvate kinase deficiency: Data from the pyruvate kinase deficiency natural history study
25. Pklr Intron Splicing-Associated Mutations and Alternate Diagnoses Are Common in Pyruvate Kinase Deficient Patients with Single or No Pklr Coding Mutations
26. Altered Splicing from a Mutated Alternate Branch Point Is Common in Severe Alpha-Spectrin Linked Inherited Anemia
27. Hemoglobin C trait accentuates erythrocyte dehydration in hereditary xerocytosis
28. CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells
29. Molecular Characterization of 140 Patients in the Pyruvate Kinase Deficiency (PKD) Natural History Study (NHS): Report of 20 New Variants
30. Brief-exposure to preoperative bevacizumab reveals a TGF-β signature predictive of response in HER2-negative breast cancers
31. Severe Alpha-Spectrin Linked Recessive Hereditary Spherocytosis
32. Molecular Phenotypes in Triple Negative Breast Cancer from African American Patients Suggest Targets for Therapy
33. The Patient With Transfusion-Dependent Anemia: Diagnosis and Directed Management With Targeted Next Generation Sequencing and Copy Number Analysis
34. Enhancers and Super Enhancers Are Associated With Genes That Control Phenotypic Traits In Primary Human Erythroid Cells
35. CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells.
36. Brief-exposure to preoperative bevacizumab reveals a TGF-b signature predictive of response in HER2-negative breast cancers.
37. Next-generation RNA sequencing reveals transcriptomic changes after brief exposure to preoperative nab-paclitaxel, bevacizumab, and trastuzumab.
38. Targeting a DNA Binding Motif of the EVI1 Protein by a Pyrrole–Imidazole Polyamide
39. Association between response to brief trastuzumab exposure in cell lines and early stage HER2+ breast tumors
40. Abstract 4719: Dynamic changes in gene expression after one dose of trastuzumab (T) reveal novel biomarkers of response to combination therapy in HER2 positive early stage breast cancer
41. GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays
42. Chromosome 7 Aneusomy in Metaplastic Breast Carcinomas With Chondroid, Squamous, and Spindle-Cell Differentiation
43. Development of a Novel Polyamide-Based Agent to Inhibit EVI1 Function
44. Analysis of a LacZ Knock-In Allele of MDS1 Indicates a Critical Role in Hematopoietic Development.
45. Role of EVI1 in Cell Cycle Regulation: Relevance of Specific Target Genes.
46. Fluorescence in situ hybridization analysis of the PRV-1 gene in polycythemia vera
47. Targeting a DNA Binding Motif of the EVI1 Protein by a Pyrrole—Imidazole Polyamide.
48. PR-domain–containing Mds1-Evi1is critical for long-term hematopoietic stem cell function
49. PklrIntron Splicing-Associated Mutations and Alternate Diagnoses Are Common in Pyruvate Kinase Deficient Patients with Single or No PklrCoding Mutations
50. Genotype-Phenotype Correlation and Molecular Heterogeneity in Pyruvate Kinase Deficiency: Data from the PKD Natural History Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.